AstraZeneca Aktie
139,85
EUR
-2,45
EUR
-1,72
%
116,08
GBP
-2,00
GBP
-1,69
%
Diese Analysten bewerten die AstraZeneca-Aktie
| Analyst | Kursziel | Abstand Kursziel | Datum | |
|---|---|---|---|---|
| Bernstein Research | 190,00 GBP | - | 17.03.2025 | |
| Goldman Sachs Group Inc. | 150,67 GBP | - | 17.03.2025 | |
| UBS AG | 142,00 GBP | - | 17.03.2025 | |
| JP Morgan Chase & Co. | 140,00 GBP | - | 17.03.2025 | |
| Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | 140,00 GBP | - | 26.02.2025 | |
| Deutsche Bank AG | 110,00 GBP | - | 12.02.2025 | |
| DZ BANK | - | - | 07.02.2025 | |
| Jefferies & Company Inc. | 109,00 GBP | - | 06.02.2025 | |
| Barclays Capital | 135,00 GBP | - | 24.06.2024 |
Werbung
Kursziele im Branchenvergleich
| Aktie | Buy | Hold | Sell | Ø Kursziel | Abst. Kursziel |
|---|---|---|---|---|---|
| Abbott Laboratories | 0 | 0 | 0 | - | - |
| Alexion Pharmaceuticals Inc. | 0 | 0 | 0 | - | - |
| APONTIS PHARMA | 0 | 0 | 0 | - | - |
| AstraZeneca PLC | 6 | 3 | 0 | 139,58 GBP | - |
| Bayer | 1 | 8 | 0 | 24,88 EUR | +3,24% |
| BioNTech (ADRs) | 4 | 2 | 0 | 131,67 USD | +38,05% |
| CanSino Biologics Inc. Registered Shs -A- | 0 | 0 | 0 | - | - |
| Celgene Corp. | 0 | 0 | 0 | - | - |
| CureVac | 0 | 1 | 0 | - | - |
| EVOTEC SE | 2 | 2 | 1 | 9,68 EUR | +52,68% |
| Gilead Sciences Inc. | 0 | 0 | 0 | - | - |
| Johnson & Johnson | 0 | 0 | 0 | - | - |
| Merck Co. | 0 | 0 | 0 | - | - |
| Merck KGaA | 7 | 1 | 0 | 180,57 EUR | +37,11% |
| Moderna Inc | 0 | 2 | 1 | 67,33 USD | +106,15% |
| Novartis AG | 3 | 5 | 1 | 99,12 CHF | -0,11% |
| Novavax Inc. | 0 | 0 | 0 | - | - |
| Pfizer Inc. | 3 | 3 | 0 | 30,20 USD | +14,92% |
| Roche AG (Genussschein) | 3 | 3 | 3 | 285,88 CHF | -7,54% |
| Roche Holding AG (Inhaberaktie) | 0 | 0 | 0 | - | - |
| Sanofi S.A. | 6 | 3 | 0 | 115,50 EUR | +9,09% |
| Shanghai Fosun Pharmaceutical (Group) Co Ltd (A) | 0 | 0 | 0 | - | - |
| Sinovac Biotech LtdShs | 0 | 0 | 0 | - | - |
| STADA | 0 | 0 | 0 | - | - |
| Teva Pharmaceutical Industries Ltd. (spons. ADRs) | 0 | 0 | 0 | - | - |
| Valneva | 0 | 0 | 0 | - | - |
| Vertex Pharmaceuticals Inc. | 0 | 0 | 0 | - | - |
| Warner Chilcott plc | 0 | 0 | 0 | - | - |